Change in bacterial causes of community-acquired parapneumonic effusion and pleural empyema in children 6 years after 13-valent pneumococcal conjugate vaccine implementation - Université de Lille Accéder directement au contenu
Article Dans Une Revue Journal of the Pediatric Infectious Diseases Society Année : 2019

Change in bacterial causes of community-acquired parapneumonic effusion and pleural empyema in children 6 years after 13-valent pneumococcal conjugate vaccine implementation

Résumé

We describe here changes in the bacterial causes of pleural empyema before and after implementation of the 13-valent pneumococcal conjugate vaccine (PCV13) program in France (2009-2017). For 220 (39.3%) of 560 children, a bacterial cause was found. The frequency of pneumococcal infection decreased during the study from 79.1% in 2009 to 36.4% in 2017 (P < .001). Group A streptococcus is now the leading cause of documented empyema (45.5%).
Fichier non déposé

Dates et versions

hal-04586282 , version 1 (24-05-2024)

Identifiants

Citer

Fouad Madhi, Corinne Levy, Laurence Morin, Philippe Minodier, Francois Dubos, et al.. Change in bacterial causes of community-acquired parapneumonic effusion and pleural empyema in children 6 years after 13-valent pneumococcal conjugate vaccine implementation. Journal of the Pediatric Infectious Diseases Society, 2019, Journal of the Pediatric Infectious Diseases Society, 8, pp.474-477. ⟨10.1093/jpids/piy103⟩. ⟨hal-04586282⟩
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More